Hepatic steatosis and advanced hepatic fibrosis are independent predictors of long-term mortality in acute myocardial infarction.

YipHan ChinJieyu LimGwyneth KongCheng Han NgRachel GohMark Dhinesh MuthiahAnurag MehtaBryan ChongChaoxing LinKai En ChanWilliam KongKian Keong PohRoger FooPing ChaiTiong-Cheng YeoAdrian F LowChi Hang LeeHuay Cheem TanMark Yan-Yee ChanA Mark RichardsPoay-Huan LohNicholas W S Chew

Published in: Diabetes, obesity & metabolism (2023)

Hepatic steatosis and advanced fibrosis have a substantial prevalence among patients with AMI. Both are associated with mortality, with an incrementally higher risk when advanced fibrosis ensues. Hepatic steatosis and fibrosis could help risk stratification of AMI patients beyond conventional risk factors.

Keyphrases

acute myocardial infarction
risk factors
end stage renal disease
cardiovascular events
percutaneous coronary intervention
ejection fraction
chronic kidney disease
newly diagnosed
left ventricular
liver fibrosis
prognostic factors
type diabetes
heart failure
patient reported outcomes
acute coronary syndrome